{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:29:08Z","timestamp":1793521748843,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021041","name":"American College of Allergy, Asthma and Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002567","name":"AAAAI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.anai.2025.06.011","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T02:46:04Z","timestamp":1749782764000},"page":"278-286.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Triple therapy vs dual inhaler therapy for moderate-to-severe asthma"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6699-3090","authenticated-orcid":false,"given":"Daniel G.","family":"Rayner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Bakaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Hoyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara T.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Rivera-Spoljaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaharu","family":"Sumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Chipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmilee M.","family":"Nyenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"O\u2019Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay E.","family":"Shade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie G.","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dia","family":"Sue-Wah-Sing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilarry","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Melendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya","family":"Winders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna D.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathyrn","family":"Przywara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B.","family":"Bacharier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Mosnaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8269-4496","authenticated-orcid":false,"given":"Derek K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2025.06.011_bib0001","unstructured":"Global Initiative for Asthma. Glob Strategy Asthma Manag Prev. 2024. https:\/\/ginasthma.org\/2024-report\/, accessed January 10, 2025."},{"issue":"9","key":"10.1016\/j.anai.2025.06.011_bib0002","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201901-0016OC","article-title":"The projected economic and health burden of uncontrolled asthma in the United States","volume":"200","author":"Yaghoubi","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2025.06.011_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106863","article-title":"The burden of mild asthma: clinical burden and healthcare resource utilisation in the NOVELTY study","volume":"200","author":"Golam","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2025.06.011_bib0004","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/JAA.S401445","article-title":"Symptom burden, health status, and productivity in patients with uncontrolled and controlled severe asthma in NOVELTY","volume":"16","author":"Ding","year":"2023","journal-title":"J Asthma Allergy"},{"issue":"22","key":"10.1016\/j.anai.2025.06.011_bib0005","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/jama.2020.21974","article-title":"Managing asthma in adolescents and adults: 2020 asthma guideline update from the National Asthma Education and Prevention Program","volume":"324","author":"Cloutier","year":"2020","journal-title":"JAMA"},{"issue":"208","key":"10.1016\/j.anai.2025.06.011_bib0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-3-642-23274-9_14","article-title":"Muscarinic receptor antagonists: effects on pulmonary function","author":"Buels","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.anai.2025.06.011_bib0007","doi-asserted-by":"crossref","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.anai.2025.06.011_bib0008","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/14712598.2023.2247972","article-title":"The economics of biosimilars and challenges to biosimilar adoption in low- and middle-income countries","volume":"23","author":"Calamia","year":"2023","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"10.1016\/j.anai.2025.06.011_bib0009","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaip.2019.08.024","article-title":"Trends and disparities in asthma biologic use in the United States","volume":"8","author":"Inselman","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"24","key":"10.1016\/j.anai.2025.06.011_bib0010","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2021.7872","article-title":"Triple vs dual inhaler therapy and asthma outcomes in moderate to severe asthma: a systematic review and meta-analysis","volume":"325","author":"Kim","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.anai.2025.06.011_bib0011","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/all.15076","article-title":"Single inhaler triple therapy (SITT) in asthma: systematic review and practice implications","volume":"77","author":"Agusti","year":"2022","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.anai.2025.06.011_bib0012","article-title":"Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis","volume":"12","author":"Oba","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.anai.2025.06.011_bib0013","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.jaip.2021.09.035","article-title":"Translating evidence to optimize Patient Care using GRADE","volume":"9","author":"Chu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.06.011_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081903","article-title":"Core GRADE 1: overview of the Core GRADE approach","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.anai.2025.06.011_bib0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.anai.2024.06.003","article-title":"Topical corticosteroids for hives and itch (urticaria): systematic review and Bayesian meta-analysis of randomized trials","volume":"133","author":"Chu","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.06.011_bib0016","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jaci.2023.08.029","article-title":"Systemic treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials","volume":"152","author":"Chu","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.06.011_bib0017","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jaci.2023.08.030","article-title":"Topical treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials","volume":"152","author":"Chu","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2025.06.011_bib0018","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jama.2024.22700","article-title":"Inhaled reliever therapies for asthma: a systematic review and meta-analysis","volume":"333","author":"Rayner","year":"2025","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.anai.2025.06.011_bib0019","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaci.2024.05.026","article-title":"Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: systematic review and meta-analysis of randomized clinical trials","volume":"154","author":"Rayner","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.06.011_bib0020","doi-asserted-by":"crossref","unstructured":"Ologundudu L, Rayner DG, Oppenheimer J, Sumino K, Hoyte F, Rivera-Spoljaric K, et al. Patient-facing digital inhalers for asthma: a systematic review and meta-analysis [e-pub ahead of print]. J Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2025.04.039, accessed May 25, 2025.","DOI":"10.1016\/j.jaip.2025.04.039"},{"key":"10.1016\/j.anai.2025.06.011_bib0021","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.anai.2025.06.011_bib0022","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/j.jaip.2022.06.017","article-title":"Trustworthy patient-centered guidelines: insights from atopic dermatitis and a proposal for the future","volume":"10","author":"Agarwal","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2025.06.011_bib0023","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","article-title":"Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations","volume":"132","author":"Panel","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2025.06.011_bib0024","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.anai.2025.06.011_bib0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jclinepi.2011.04.015","article-title":"Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid","volume":"65","author":"Akl","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.anai.2025.06.011_bib0026","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence\u2013publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.anai.2025.06.011_bib0027","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.anai.2025.06.011_bib0028","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jrsm.46","article-title":"Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability","volume":"2","author":"Thorlund","year":"2011","journal-title":"Res Synth Methods"},{"issue":"5","key":"10.1016\/j.anai.2025.06.011_bib0029","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","article-title":"Measurement properties and interpretation of three shortened versions of the asthma control questionnaire","volume":"99","author":"Juniper","year":"2005","journal-title":"Respir Med"},{"issue":"32","key":"10.1016\/j.anai.2025.06.011_bib0030","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.anai.2025.06.011_bib0031","doi-asserted-by":"crossref","first-page":"k4388","DOI":"10.1136\/bmj.k4388","article-title":"Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis","volume":"363","author":"Zheng","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.anai.2025.06.011_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-083864","article-title":"Core GRADE 4: rating certainty of evidence-risk of bias, publication bias, and reasons for rating up certainty","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.anai.2025.06.011_bib0033","article-title":"Core GRADE 3: rating certainty of evidence-assessing inconsistency","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.anai.2025.06.011_bib0034","article-title":"Core GRADE 5: rating certainty of evidence-assessing indirectness","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.anai.2025.06.011_bib0035","article-title":"Core GRADE 2: choosing the target of certainty rating and assessing imprecision","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.anai.2025.06.011_bib0036","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.anai.2025.06.011_bib0037","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.anai.2025.06.011_bib0038","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2021.03.026","article-title":"GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings","volume":"137","author":"Zeng","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.anai.2025.06.011_bib0039","series-title":"Compared add-on tiotropium handihaler and increasing dose of ICS in moderate and severe adult asthma who controlled with ICS\/LABA","author":"Aunanan","year":"2020"},{"issue":"6","key":"10.1016\/j.anai.2025.06.011_bib0040","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.rmed.2006.11.001","article-title":"A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma","volume":"101","author":"Fardon","year":"2007","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.anai.2025.06.011_bib0041","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01100-2016","article-title":"A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma","volume":"49","author":"Hamelmann","year":"2017","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.anai.2025.06.011_bib0042","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2500\/aap.2016.37.3991","article-title":"Effects of the addition of tiotropium on airway dimensions in symptomatic asthma","volume":"37","author":"Hoshino","year":"2016","journal-title":"Allergy Asthma Proc"},{"issue":"9","key":"10.1016\/j.anai.2025.06.011_bib0043","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/02770903.2018.1514047","article-title":"Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting \u03b22-agonist in for patients with asthma","volume":"56","author":"Hoshino","year":"2019","journal-title":"J Asthma"},{"issue":"8","key":"10.1016\/j.anai.2025.06.011_bib0044","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5414\/CP203382","article-title":"Effect of triple therapy in patients with asthma-COPD overlap","volume":"57","author":"Ishiura","year":"2019","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.anai.2025.06.011_bib0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/COPD.S231004","article-title":"Triple therapy with budesonide\/glycopyrrolate\/formoterol fumarate improves inspiratory capacity in patients with asthma-chronic obstructive pulmonary disease overlap","volume":"15","author":"Ishiura","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.anai.2025.06.011_bib0046","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2147\/JAA.S360260","article-title":"Tiotropium Add-On and treatable traits in asthma-COPD overlap: A real-world pilot study","volume":"15","author":"Ishiura","year":"2022","journal-title":"J Asthma Allergy"},{"issue":"10","key":"10.1016\/j.anai.2025.06.011_bib0047","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/cea.12972","article-title":"Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma","volume":"47","author":"Jabbal","year":"2017","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.anai.2025.06.011_bib0048","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/cea.13702","article-title":"Randomized controlled trial of triple versus dual inhaler therapy on small airways in smoking asthmatics","volume":"50","author":"Jabbal","year":"2020","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.anai.2025.06.011_bib0049","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15586\/aei.v51i4.876","article-title":"Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome","volume":"51","author":"Jiang","year":"2023","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"2","key":"10.1016\/j.anai.2025.06.011_bib0050","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2011.04.039","article-title":"Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial","volume":"128","author":"Kerstjens","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"13","key":"10.1016\/j.anai.2025.06.011_bib0051","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.anai.2025.06.011_bib0052","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.anai.2025.06.011_bib0053","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1080\/02770903.2021.1938603","article-title":"A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS\/LABA treatment","volume":"59","author":"Kerwin","year":"2022","journal-title":"J Asthma"},{"issue":"1","key":"10.1016\/j.anai.2025.06.011_bib0054","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.anai.2025.06.011_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124109","article-title":"Long-term once-daily tiotropium Respimat\u00ae is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study","volume":"10","author":"Ohta","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.anai.2025.06.011_bib0056","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jaip.2020.09.066","article-title":"A randomized, noninferiority trial comparing ICS + LABA with ICS + LABA + LAMA in asthma-COPD overlap (ACO) treatment: the ACO treatment with optimal medications (ATOMIC) study","volume":"9","author":"Park","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2025.06.011_bib0057","unstructured":"Singh. A Multicentre, Randomised, Double-Blind, Active-Controlled, 3-Way Cross-Over Study to Evaluate the Efficacy and Safety of a Free Combination of 3 Doses of CHF 5259 (Glycopyrrolate) Plus Foster\u00ae 100\/6\u00b5g (Fixed Combination of Beclomethasone Dipropionate Plus Formoterol) in a Metered Dose Inhaler for the Treatment of Patients With Uncontrolled Asthma Under Medium Doses of Inhaled Corticosteroids Plus Long-Acting \u03b22-Agonists; 2014. https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2013-003043-36\/results, accessed January 10, 2025."},{"issue":"5","key":"10.1016\/j.anai.2025.06.011_bib0058","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2017.01.014","article-title":"A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma","volume":"140","author":"Szefler","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"10210","key":"10.1016\/j.anai.2025.06.011_bib0059","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(19)32215-9","article-title":"Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials","volume":"394","author":"Virchow","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.anai.2025.06.011_bib0060","first-page":"19476","article-title":"Assessment of second-line treatments for patients with uncontrolled moderate asthma","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.anai.2025.06.011_bib0061","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12931-020-01349-5","article-title":"Letter to the editor: indacaterol\/glycopyrronium\/mometasone furoate compared with salmeterol\/fluticasone propionate in patients with asthma: a randomized controlled cross-over study","volume":"21","author":"Watz","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.anai.2025.06.011_bib0062","doi-asserted-by":"crossref","first-page":"944","DOI":"10.12659\/MSM.907950","article-title":"Therapeutic effects of a long-acting cholinergic receptor blocker, tiotropium bromide, on asthma","volume":"24","author":"Zhang","year":"2018","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.anai.2025.06.011_bib0063","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pedneo.2013.10.003","article-title":"Correlations between pulmonary function and childhood asthma control test results in 5-11-year-old children with asthma","volume":"55","author":"Lee","year":"2014","journal-title":"Pediatr Neonatol"},{"issue":"1","key":"10.1016\/j.anai.2025.06.011_bib0064","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15612-w","article-title":"FVC, but not FEV1, is associated with clinical outcomes of asthma-COPD overlap","volume":"12","author":"An","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.anai.2025.06.011_bib0065","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jaip.2019.04.019","article-title":"Association between pulmonary function and asthma symptoms","volume":"7","author":"Sullivan","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.06.011_bib0066","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jaci.2024.07.016","article-title":"Applying the dissemination and implementation sciences to allergy and immunology: A Work Group Report from the AAAAI Quality, Adherence, and Outcomes Committee","volume":"154","author":"Kakumanu","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2025.06.011_bib0067","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2147\/JAA.S424055","article-title":"Real-world study of single-inhaler triple therapy with fluticasone furoate\/Umeclidinium\/Vilanterol on asthma control in the US","volume":"16","author":"Bogart","year":"2023","journal-title":"J Asthma Allergy"},{"issue":"1s","key":"10.1016\/j.anai.2025.06.011_bib0068","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jaip.2021.10.011","article-title":"A practical guide to implementing SMART in asthma management","volume":"10","author":"Reddel","year":"2022","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112062500287X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112062500287X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:35:38Z","timestamp":1762364138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108112062500287X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S108112062500287X"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.06.011","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple therapy vs dual inhaler therapy for moderate-to-severe asthma","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}